WO2013009146A3 - 당뇨망막병증 진단용 마커 및 이의 용도 - Google Patents
당뇨망막병증 진단용 마커 및 이의 용도 Download PDFInfo
- Publication number
- WO2013009146A3 WO2013009146A3 PCT/KR2012/005626 KR2012005626W WO2013009146A3 WO 2013009146 A3 WO2013009146 A3 WO 2013009146A3 KR 2012005626 W KR2012005626 W KR 2012005626W WO 2013009146 A3 WO2013009146 A3 WO 2013009146A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diabetic retinopathy
- diagnosing diabetic
- marker
- diagnosing
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
- G01N2800/164—Retinal disorders, e.g. retinopathy
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
본 발명은 당뇨망막병증 환자의 진단 및 진행 정도 판단을 위해 사용될 수 있는 유전자 또는 단백질 수준을 측정하는 제제를 포함하는 당뇨망막병증 진단용 조성물, 키트, 이를 사용한 당뇨망막병증 진단을 위한 정보 제공 방법 및 당뇨망막병증 진단방법에 관한 것이다.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020110070123A KR101391506B1 (ko) | 2011-07-14 | 2011-07-14 | 당뇨망막병증 진단용 마커 및 이의 용도 |
| KR10-2011-0070123 | 2011-07-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2013009146A2 WO2013009146A2 (ko) | 2013-01-17 |
| WO2013009146A3 true WO2013009146A3 (ko) | 2013-04-25 |
Family
ID=47506753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2012/005626 Ceased WO2013009146A2 (ko) | 2011-07-14 | 2012-07-13 | 당뇨망막병증 진단용 마커 및 이의 용도 |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR101391506B1 (ko) |
| WO (1) | WO2013009146A2 (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102000827B1 (ko) | 2017-08-03 | 2019-07-16 | 건국대학교 산학협력단 | 당뇨병성망막증 진단용 바이오마커 및 이의 용도 |
| WO2020179953A1 (ko) * | 2019-03-07 | 2020-09-10 | (주)레티마크 | 당뇨망막병증 진단용 복합 마커 및 이의 용도 |
| WO2020189821A1 (ko) * | 2019-03-20 | 2020-09-24 | (주)레티마크 | 실명 유발 주요 안질환 진단용 혈액 마커 및 이를 이용한 진단 방법 |
| WO2021150011A1 (ko) * | 2020-01-22 | 2021-07-29 | 계명대학교 산학협력단 | 당뇨 조기진단 또는 당뇨병성 합병증 진단을 위한 바이오마커 및 이의 용도 |
| RU2765437C1 (ru) * | 2021-08-17 | 2022-01-31 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ГБ им. Гельмгольца" Минздрава России) | Способ определения уровня экспрессии гена, кодирующего PEDF, в тканях глаза кролика Oryctolagus cuniculus и набор для его определения |
| WO2024073355A2 (en) * | 2022-09-26 | 2024-04-04 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for monitoring molecular biomarkers for aging and disease |
| KR102480069B1 (ko) * | 2022-09-08 | 2022-12-26 | 줄리아 연구소 주식회사 | 바이오마커를 이용한 당뇨망막병증 진단용 조성물, 당뇨망막병증 진단을 위한 정보제공방법 및 당뇨망막병증 치료용 물질의 스크리닝 방법 |
-
2011
- 2011-07-14 KR KR1020110070123A patent/KR101391506B1/ko active Active
-
2012
- 2012-07-13 WO PCT/KR2012/005626 patent/WO2013009146A2/ko not_active Ceased
Non-Patent Citations (3)
| Title |
|---|
| BEN-BO GAO ET AL., JOURNAL OFPROTEOME RESEARCH., vol. 7, no. 6, 24 April 2008 (2008-04-24), pages 2516 - 2525, XP055028561 * |
| KYOUNG KON KIM., THESIS FOR DOCTOR'S DEGREE IN SEOUL UNIVERSITY., 2010 * |
| KYUNGGON KIM ET AL., JOURNAL OFPROTEOME RESEARCH., vol. 9, no. 2, 18 December 2009 (2009-12-18), pages 689 - 699, XP055064106 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013009146A2 (ko) | 2013-01-17 |
| KR101391506B1 (ko) | 2014-05-07 |
| KR20130009205A (ko) | 2013-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2013009146A3 (ko) | 당뇨망막병증 진단용 마커 및 이의 용도 | |
| WO2009085234A3 (en) | Use of micro-rna as a biomarker of immunomodulatory drug activity | |
| HK1210831A1 (en) | Compositions and methods for detecting protease activity in biological systems | |
| WO2011015944A3 (en) | Use of free dna as an early predictor of severity in acute pancreatitis | |
| WO2014020502A3 (en) | Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2) | |
| EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
| WO2012021407A3 (en) | Biomarkers for stroke | |
| WO2013163568A3 (en) | Methods for evaluating lung cancer status | |
| WO2013153461A3 (en) | Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases | |
| WO2010136163A8 (en) | Secernin-1 as a marker for cancer | |
| ATE554389T1 (de) | Apex als marker für lungenkrebs | |
| WO2009149319A3 (en) | Gene expression profiles associated with asthma exacerbation attacks | |
| WO2011156734A3 (en) | Method of characterizing vascular diseases | |
| WO2012107841A3 (en) | Micro -rna biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof | |
| WO2010097186A8 (en) | Use of s-erbb-3 as a marker for cancer | |
| WO2014043633A8 (en) | Use of e-cadherin and vimentin for selection of treatment responsive patients | |
| EP3285071A4 (en) | Biomarker composition for diagnosing still's disease, diagnostic kit, and diagnostic method | |
| AU2012339149A8 (en) | Method for the diagnosis of Niemann-Pick disease | |
| BR112014031957A2 (pt) | bag3 como soro bioquímico e marcador de tecido | |
| WO2013009143A3 (ko) | 당뇨망막병증 진단용 마커 및 이의 용도 | |
| WO2012049225A3 (de) | Markersequenzen für systemischer lupus erythematodes und deren verwendung | |
| WO2015069883A3 (en) | Oxidized fraction of extracellular dna as a biomarker of stress and methods for using the same | |
| WO2012081007A3 (en) | Methods of diagnosing and treating pancreatic cancer | |
| WO2011003623A3 (de) | Verfahren und marker zur individuellen prognose und/oder zur individuellen erfassung einer neuropathie | |
| WO2014117680A3 (zh) | 外周血细胞TRPC6mRNA水平用于早期预测/诊断老年性痴呆 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12811124 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 12811124 Country of ref document: EP Kind code of ref document: A2 |